Rhovac CEO quits after failed study
![Photo: Frank Molter/AP/Ritzau Scanpix](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14083561.ece/ALTERNATES/schema-16_9/20255122033225-3374x1899ma.jpg)
Anders Månsson’s days as chief executive of biotech firm Rhovac are numbered, as he has announced his intention to leave his role no later than Sept. 30, according to a Friday press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Orion enters partnership with MSD, upgrades guidance
For subscribers
Rhovac is open to all sale and partnership opportunities
For subscribers